Drug Development

Articles

The patent was filed for a chewing gum composition with controlled release of cannabinoids and opioid agonists, and antagonists for addiction or dependence treatment. 


AXIM Files Patent Application for Controlled-Release Chewing Gum for Opioid Addiction

The agency recommended approval of treatments for hepatitis C, cancer, multiple sclerosis, and arthritis.


EMA Recommends Approval for Eight New Drugs, One Biosimilar

A loan from the European Investment Bank will give BiondVax resources for Phase III trials and a manufacturing facility for its universal flu vaccine.


BiondVax Receives European Union Investment in Universal Flu Vaccine Development

FDA Commissioner Scott Gottlieb announced the agency will hold a public meeting on drug competition as part of its Drug Competition Action Plan. 


FDA Announces Public Meeting on Generic Drugs

The European Commission approved Rixathon for use in all indications of its reference medicine, MabThera. 


Sandoz Scores European Approval for Biosimilar Rituximab

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

The landmark decision determined that biosimilar makers can notify manufacturers before receiving FDA approval. 


Supreme Court Rules in Amgen v. Sandoz

The United Kingdom’s Center for Process Innovation (CPI) is investing in a new project, Microstar, which seeks to reduce risk for formulators through the development of accelerated screening methods for predictive design.

New Project Seeks to Develop Novel Microfluidic Chip for Quick Formulation Stability Screening

Takeda will build a new production facility at its existing Grange Castle site in Ireland.

Takeda Constructs High-Containment Facility in Ireland

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

As cost pressures mount as a result of multiple biologics being developed for the same indication, manufacturers can harness process efficiencies to maintain the value of legacy products.


Boosting Bioproduction Workflows with Automation Technologies

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Industry experts discuss best practices for dissolution testing of poorly soluble, immediate-release, and controlled-release formulations and the different analytical approaches used.

Formulation and Drug Delivery